Adrian Ryan Guzman

Adrian Ryan Guzman

Auto-generated profile, based on publicly available information

Adrian Ryan Guzman

Department of Electrical and Computer Engineering, Texas A&M University, College Station, USA

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 September 2017 in Plant Direct
Verified
Journal Article
Open access
PDF file
HKHyun Soo Kim
Hyun Soo Kim
SHShih‐Chi Hsu
Shih‐Chi Hsu
SHSong‐I Han
Song‐I Han
HTHem R. Thapa
Hem R. Thapa
AGAdrian R. Guzman
Adrian R. Guzman
Arum HanArum Han
Arum Han
Biofuels derived from microalgal lipids have demonstrated a promising potential as future renewable bioenergy. However, the production costs for microalgae‐based biofuels are not economically competitive, and one strategy to overcome this limitation is to develop better‐performing microalgal strains that have faster growth and higher lipid content through genetic screening and metabolic engineering. In this work, we present a high‐throughput droplet microfluidics‐based screening platform capable of analyzing growth and lipid content in populations derived from single cells of a randomly mutated microalgal library to identify and sort variants that exhibit the desired traits such as higher growth rate and increased lipid content. By encapsulating single cells into water‐in‐oil emulsion droplets, each variant was separately cultured inside an individual droplet that functioned as an independent bioreactor. In conjunction with an on‐chip fluorescent lipid staining process within droplets, microalgal growth and lipid content were characterized by measuring chlorophyll and BODIPY fluorescence intensities through an integrated optical detection system in a flow‐through manner. Droplets containing cells with higher growth and lipid content were selectively retrieved and further analyzed off‐chip. The growth and lipid content screening capabilities of the developed platform were successfully demonstrated by first carrying out proof‐of‐concept screening using known Chlamydomonas reinhardtii mutants. The platform was then utilized to screen an ethyl methanesulfonate (EMS)‐mutated C. reinhardtii population, where eight potential mutants showing faster growth and higher lipid content were selected from 200,000 examined samples, demonstrating the capability of the platform as a high‐throughput screening tool for microalgal biofuel development.

1 January 2016 in Biotechnology and Bioengineering
Verified
Journal Article
Closed access
PDF file
HKHyun Soo Kim
Hyun Soo Kim
AGAdrian R. Guzman
Adrian R. Guzman
HTHem R. Thapa
Hem R. Thapa
TDTimothy P. Devarenne
Timothy P. Devarenne
Arum HanArum Han
Arum Han

15 February 2015 in Biomedical Microdevices
Verified
Journal Article
Closed access
PDF file
AGAdrian R. Guzman
Adrian R. Guzman
HKHyun Soo Kim
Hyun Soo Kim
PFPaul de Figueiredo
Paul de Figueiredo
Arum HanArum Han
Arum Han

8 July 2022 in Science Advances
Verified
Journal Article
Open access
HZHan Zhang
Han Zhang
CHCan Huang
Can Huang
YLYuwen Li
Yuwen Li
RGRohit Gupte
Rohit Gupte
RSRyan Samuel
Ryan Samuel
Arum HanArum Han
Arum Han
Droplet microfluidic systems have been widely deployed to interrogate biological and chemical systems. The major limitations of these systems are the relatively high error rates from critical droplet manipulation functions. To address these limitations, we describe the development of FIDELITY (Flotation and Interdigitated electrode forces on Droplets to Enable Lasting system IntegriTY), a highly sensitive and accurate size-based droplet bandpass filter that leverages the natural buoyancy of aqueous droplets and highly localized dielectrophoretic force generated by interdigitated electrode arrays. Droplet manipulation accuracies greater than 99% were achieved at a throughput of up to 100 droplets/s and separation of droplets that differed in diameter by only 6 μm was demonstrated. Last, the utility of FIDELITY was demonstrated in a droplet size quality control application and also in a droplet-based in vitro transcription/translation workflow. We anticipate FIDELITY to be integrated into a broad range of droplet microfluidic configurations to achieve exceptional operational accuracy.

11 February 2016 in RSC Advances
Verified
Journal Article
Closed access
PDF file
JDJing Dai
Jing Dai
HKHyun Soo Kim
Hyun Soo Kim
AGAdrian Ryan Guzman
Adrian Ryan Guzman
WSWon-Bo Shim
Won-Bo Shim
Arum HanArum Han
Arum Han
In many droplet-based screening applications, applying an equal incubation or reaction time to a large number of droplets is critical since differences in incubation time can lead to false positive or false negative hits during the selection process. Even though many droplet incubation platforms have been successfully utilized, having all droplets incubated for equal duration remains a formidable challenge. Here, we present an on-chip droplet incubation chamber that is capable of providing a constant droplet incubation time for a large number of droplets. This first-in first-out droplet incubation chamber essentially functions as a delay compartment to ensure that all droplets have equal incubation time inside the chamber before moving on to the post-incubation assay steps. The functionality of the developed chamber was tested by tracking color dye droplets flowing through the on-chip incubation chamber as well as comparing the growth of droplet-encapsulated cells of a filamentous fungus Fusarium verticillioides. The incubation time can be easily adjusted by changing the volume of the chamber or droplet collection speed. The chamber can also be easily integrated on-chip with other droplet microfluidics functional modules such as droplet generators, detectors, and sorters without any valve and tubing connection.

1 November 2024 in Nature Communications
Verified
Journal Article
Open access
PDF file
HZHan Zhang
Han Zhang
RGRohit Gupte
Rohit Gupte
YLYuwen Li
Yuwen Li
CHCan Huang
Can Huang
AGAdrian R. Guzman
Adrian R. Guzman
Arum HanArum Han
Arum Han
High-throughput screening techniques are pivotal to unlocking the mysteries of biology. Yet, the promise of droplet microfluidics in enabling single-cell resolution, ultra-high-throughput screening remains largely unfulfilled. Droplet sorting errors caused by polydisperse droplet sizes that are often inevitable in multi-step assays have severely limited the effectiveness and utility of this technique, especially when screening large libraries. Even a relatively low 1% sorting error results in 10,000 false calls in a 1,000,000 droplet screen, imposing an unreasonably large burden on downstream validation. Here, we present NOVAsort (Next-generation Opto-Volume-based Accurate droplet sorter), a device capable of discerning droplets based on both size and fluorescence intensity. With a 1000- and 10,000-fold reduction in false positives and false negatives, respectively. NOVAsort addresses the challenges of conventional droplet sorting approaches and sets standards for accuracy and throughput in droplet microfluidic assays.